AngioDynamics, Inc. (ANGO)

About AngioDynamics, Inc.

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Super investor ownership

10 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

• Steve Cohen, Point72 Asset Management, L.P.$39.84M · 0.0% of book
• Israel Englander, MILLENNIUM MANAGEMENT LLC$10.19M · 0.0% of book
• Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$9.55M · 0.0% of book
• Arrowstreet Capital, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$9.01M · 0.0% of book
• Cliff Asness, AQR CAPITAL MANAGEMENT LLC$7.66M · 0.0% of book

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in ANGO

Trades in ANGO disclosed by members of Congress and executive-branch officials, latest first:

• Debbie Wasserman Schultz · HouseSell · $1,001 - $15,000 · traded 16 Jul 2025 · disclosed 25 Jul 2025
• Debbie Wasserman Schultz · HouseBuy · $1,001 - $15,000 · traded 27 Jun 2025 · disclosed 25 Jul 2025
• Debbie Wasserman Schultz · HouseBuy · $1,001 - $15,000 · traded 27 Apr 2016 · disclosed 6 Jul 2016

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

Common questions